Sign in

CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company

Phio Pharmaceuticals Corp.

Sign in to watch
Ticker
PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453215903
Phone
(508) 767-3861
Business address
411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
Former names
RXi Pharmaceuticals Corp
Open-market buys, last 90 days
$104,806
in 9 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$104,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 55 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-02-13 Kontulis Caitlin Secretary & Sr. Dir. Finance Grant or award +27,000 40,214
2019-02-13 Dispersyn Gerrit President & COO Grant or award +55,000 71,350
2019-02-01 CAUWENBERGH GEERT Chief Executive Officer Grant or award +21,470 $0.38 $8K 306,898
2019-01-18 CAUWENBERGH GEERT Chief Executive Officer Grant or award +23,729 $0.34 $8K 285,428
2019-01-04 CAUWENBERGH GEERT Chief Executive Officer Grant or award +23,139 $0.35 $8K 261,699
2018-12-21 CAUWENBERGH GEERT Chief Executive Officer Grant or award +27,445 $0.30 $8K 238,560
2018-12-07 CAUWENBERGH GEERT Chief Executive Officer Grant or award +21,882 $0.37 $8K 211,115
2018-11-23 CAUWENBERGH GEERT Chief Executive Officer Grant or award +25,941 $0.31 $8K 189,233
2018-11-09 CAUWENBERGH GEERT President & CEO Grant or award +18,698 $0.43 $8K 163,292
2018-10-26 CAUWENBERGH GEERT President & CEO Grant or award +18,519 $0.44 $8K 144,594
2018-10-12 CAUWENBERGH GEERT President & CEO Grant or award +17,230 $0.47 $8K 126,075
2018-09-28 CAUWENBERGH GEERT President & CEO Grant or award +73,587 $1.17 $86K 108,845
2018-08-01 Lockshin Curtis Director Grant or award +10,000 10,130
2018-08-01 Freeman Jonathan E Director Grant or award +10,000 10,000
2018-08-01 Dorman H. Paul Director Grant or award +10,000 10,375
2018-08-01 Brownlie Keith L Director Grant or award +10,000 10,000
2018-08-01 Bitterman Robert J Director Grant or award +10,000 10,440
2018-08-01 CAUWENBERGH GEERT President & CEO Grant or award +21,000 35,258
2018-08-01 CAUWENBERGH GEERT President & CEO Grant or award · Stock option (right to buy) +21,000 21,000
2018-08-01 Dispersyn Gerrit Chief Development Officer Grant or award +16,000 16,350

Page 7 of 13 · 258 trades